Stabilization and regression of coronary atherosclerotic plaques by lipid-lowering therapy plays an important role in the treatment of (CHD). Plaque regression, which includes the removal of lipids and the necrotic core, was shown to restore endothelial function, although the cessation of intravascular smooth muscle cell proliferation is a complex process.